{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:50:36Z","timestamp":1783576236073,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Arivale"},{"name":"Institute for Systems Biology"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30ES017885-01A1"],"award-info":[{"award-number":["P30ES017885-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016611","name":"Andy Hill Cancer Research Endowment Fund","doi-asserted-by":"crossref","award":["BRK_201801-05"],"award-info":[{"award-number":["BRK_201801-05"]}],"id":[{"id":"10.13039\/100016611","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We analyzed 1196 proteins in longitudinal plasma samples from participants in a commercial wellness program, including samples collected pre-diagnosis from ten cancer patients and 69 controls. For three individuals ultimately diagnosed with metastatic breast, lung, or pancreatic cancer, CEACAM5 was a persistent longitudinal outlier as early as 26.5\u00a0months pre-diagnosis. CALCA, a biomarker for medullary thyroid cancer, was hypersecreted in metastatic pancreatic cancer at least 16.5\u00a0months pre-diagnosis. ERBB2 levels spiked in metastatic breast cancer between 10.0 and 4.0\u00a0months pre-diagnosis. Our results support the value of deep phenotyping seemingly healthy individuals in prospectively inferring disease transitions.<\/jats:p>","DOI":"10.1038\/s41598-020-73451-z","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T10:05:01Z","timestamp":1601546701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Andrew T.","family":"Magis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Rappaport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Conomos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert S.","family":"Omenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leroy","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"73451_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/pme.13.57","volume":"10","author":"M Flores","year":"2013","unstructured":"Flores, M., Glusman, G., Brogaard, K., Price, N. D. & Hood, L. P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med 10, 565\u2013576 (2013).","journal-title":"Per Med"},{"key":"73451_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S1470-2045(14)70091-9","volume":"15","author":"M Cristofanilli","year":"2014","unstructured":"Cristofanilli, M. Circulating tumour cells: telling the truth about metastasis. Lancet Oncol. 15, 365\u2013366 (2014).","journal-title":"Lancet Oncol."},{"key":"73451_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach, H., Hoon, D. S. B. & Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426\u2013437 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"73451_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc1043","volume":"3","author":"JD Wulfkuhle","year":"2003","unstructured":"Wulfkuhle, J. D., Liotta, L. A. & Petricoin, E. F. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 3, 267\u2013275 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"73451_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"73451_CR6","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1038\/s41598-019-43058-0","volume":"9","author":"N Zubair","year":"2019","unstructured":"Zubair, N. et al. Genetic predisposition impacts clinical changes in a lifestyle coaching program. Sci. Rep. 9, 6805 (2019).","journal-title":"Sci. Rep."},{"key":"73451_CR7","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg, M., Eriksson, A., Tran, B., Assarsson, E. & Fredriksson, S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 39, e102\u2013e102 (2011).","journal-title":"Nucleic Acids Res."},{"key":"73451_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2407-7-2","volume":"7","author":"RD Blumenthal","year":"2007","unstructured":"Blumenthal, R. D., Leon, E., Hansen, H. J. & Goldenberg, D. M. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer 7, 2 (2007).","journal-title":"BMC Cancer"},{"key":"73451_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-013-9444-6","volume":"32","author":"N Beauchemin","year":"2013","unstructured":"Beauchemin, N. & Arabzadeh, A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev 32, 643\u2013671 (2013).","journal-title":"Cancer Metastasis Rev"},{"key":"73451_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/archderm.143.5.613","volume":"143","author":"D Sariya","year":"2007","unstructured":"Sariya, D. et al. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch. Dermatol 143, 613\u2013620 (2007).","journal-title":"Arch. Dermatol"},{"key":"73451_CR11","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet.45, 1113\u20131120 (2013).","DOI":"10.1038\/ng.2764"},{"key":"73451_CR12","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1210\/jc.2007-2496","volume":"93","author":"K Cheung","year":"2008","unstructured":"Cheung, K., Roman, S. A., Wang, T. S., Walker, H. D. & Sosa, J. A. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J. Clin. Endocrinol. Metab. 93, 2173\u20132180 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"73451_CR13","first-page":"151","volume":"23","author":"H Goebell","year":"1976","unstructured":"Goebell, H. The role of calcium in pancreatic secretion and disease. Acta Hepatogastroenterol (Stuttg) 23, 151\u2013161 (1976).","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"key":"73451_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00006676-199805000-00014","volume":"16","author":"A Fleury","year":"1998","unstructured":"Fleury, A. et al. Calcitonin-secreting tumors of the pancreas: about six cases. Pancreas 16, 545\u2013550 (1998).","journal-title":"Pancreas"},{"key":"73451_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/MPA.0b013e3182015f5d","volume":"40","author":"R Schneider","year":"2011","unstructured":"Schneider, R. et al. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas 40, 213\u2013221 (2011).","journal-title":"Pancreas"},{"key":"73451_CR16","doi-asserted-by":"crossref","unstructured":"Giannetta, E. et al. Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports. Medicine (Baltimore)95, e2419 (2016).","DOI":"10.1097\/MD.0000000000002419"},{"key":"73451_CR17","first-page":"70","volume":"7","author":"S Delis","year":"2006","unstructured":"Delis, S. et al. Asymptomatic calcitonin-secreting tumor of the pancreas: a case report. JOP 7, 70\u201373 (2006).","journal-title":"JOP"},{"key":"73451_CR18","doi-asserted-by":"crossref","unstructured":"Jensen, C. H. et al. Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur. J. Biochem.225, 83\u201392 (1994).","DOI":"10.1111\/j.1432-1033.1994.00083.x"},{"key":"73451_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41523-018-0062-x","volume":"4","author":"E Powell","year":"2018","unstructured":"Powell, E. et al. A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis. NPJ Breast Cancer 4, 9 (2018).","journal-title":"NPJ Breast Cancer"},{"key":"73451_CR20","doi-asserted-by":"publisher","first-page":"19543","DOI":"10.1074\/jbc.M410943200","volume":"280","author":"S Fabre-Lafay","year":"2005","unstructured":"Fabre-Lafay, S. et al. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)\/ADAM-17. J. Biol. Chem. 280, 19543\u201319550 (2005).","journal-title":"J. Biol. Chem."},{"key":"73451_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1158\/1055-9965.EPI-06-1008","volume":"16","author":"LR Rodrigues","year":"2007","unstructured":"Rodrigues, L. R., Teixeira, J. A., Schmitt, F. L., Paulsson, M. & Lindmark-M\u00e4nsson, H. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol. Biomarkers Prev. 16, 1087\u20131097 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"73451_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73451-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73451-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73451-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:07:54Z","timestamp":1670357274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73451-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73451"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73451-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Arivale, which closed in May 2019, partially funded this study. At the time this study was conceived and designed, multiple authors held positions and\/or held stock options in the company. The authors declare no ongoing financial interests in Arivale. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16275"}}